<DOC>
	<DOCNO>NCT00757835</DOCNO>
	<brief_summary>A crossover , randomize , single-masked study compare short-term ( 3 month ) 24-hour IOP control safety travoprost/timolol fix combination give evening , versus latanoprost/timolol fix combination give even patient exfoliative glaucoma . The primary objective trial compare quality 24-hour IOP control 3 month chronic therapy two medication .</brief_summary>
	<brief_title>24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol XFG</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Patient XFG old 29 year The IOP without treatment great 25 mm Hg low 40 mm Hg baseline ( 2 reading 10:00 ) Patient safely wash without risk significant deterioration Distance best correct Snelen visual acuity well 0.1 No contraindication prostaglandins Î²blockers No history lack response ( &lt; 10 % reduction ) medication Patient understand instruction comply medication Open normal appear angle No sign ocular infection , except blepharitis , corneal abnormality may affect IOP measurement etc History trauma , inflammation , surgery , past use steroid ( within 2 month ) , severe dry eye use contact lens Patient female childbearing potential lactating mother</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>24-hour IOP</keyword>
	<keyword>exfoliative glaucoma</keyword>
	<keyword>travoprost/timolol</keyword>
	<keyword>latanoprost/timolol</keyword>
	<keyword>fix combination</keyword>
</DOC>